MARK CRUCIANI: Open Payments
NPI 1235171646 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 26 payments from 7 companies in 2025. Trend: 2023 $701 · 2024 $676 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $190 |
| GlaxoSmithKline, LLC. | 7 | $187 |
| UCB, Inc. | 3 | $70 |
| Amgen Inc. | 3 | $70 |
| Radius Health, Inc. | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $19 |
| SOBI, INC | 1 | $18 |
Products named: BENLYSTA, RINVOQ, Bimzelx, SKYRIZI, OTEZLA, Tymlos, ENBREL, TREMFYA.
Industry payments across PA — which companies pay providers there.
